SCHEMBL6797100

SCHEMBL6797100

Cc1cc(Nc2cccc3nc4ccccc4c(C)c23)ccc1N

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.46
RAB9A P51151 4/20 0.46
NPC1 O15118 3/20 0.46
TAAR1 Q96RJ0 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
KDM1A O60341 4/20 0.43
MEN1 O00255 3/20 0.43
LMNA P02545 3/20 0.43
PKM P14618 2/20 0.41
SLC2A1 P11166 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP3A4 P08684 1/20 0.40
THRB P10828 1/20 0.40
ALOX15 P16050 1/20 0.40
RECQL P46063 1/20 0.40
HIF1A Q16665 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6792609 0.80 KDM1A (0.62) KMT2ARAB9ANPC1TAAR1L3MBTL1
SCHEMBL6786741 0.79 NPC1 (0.46) KMT2ARAB9ANPC1TAAR1L3MBTL1
SCHEMBL6801290 0.78 MAPT (0.51) KMT2ARAB9ANPC1L3MBTL1MEN1
SCHEMBL31426816 0.73 TDP1 (0.56) KMT2ARAB9AMEN1LMNASMN1; SMN2
SCHEMBL13973364 0.73 TDP1 (0.56) KMT2ARAB9AMEN1LMNASMN1; SMN2
SCHEMBL30998047 0.70 ALDH1A1 (0.70) KMT2AL3MBTL1MEN1LMNAALDH1A1
SCHEMBL2127369 0.70 ALDH1A1 (0.70) KMT2AL3MBTL1MEN1LMNAALDH1A1
SCHEMBL6882649 0.69 KDM1A (0.62) KMT2ARAB9ANPC1TAAR1L3MBTL1
SCHEMBL22201552 0.68 ALDH1A1 (0.70) KMT2AMEN1LMNASMN1; SMN2ALDH1A1
SCHEMBL8390746 0.67 GPR3 (0.50) KMT2ARAB9ANPC1L3MBTL1KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040198765-A1 5-(9-ACRIDINYLAMINO)-TOLUIDINE COMPOUNDS ACADEMIA SINICA (TW) 2004-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040198765-A1 5-(9-ACRIDINYLAMINO)-TOLUIDINE COMPOUNDS DPP9, NANP, NAT1 KMT2A 2871/4885RAB9A 100/4885NPC1 283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.